Orion pharmaceutical research earmarked for EIB money

14-Aug-2009

EIB to lend Orion Euro 75m to help pharmaceutical research and development work

The European Investment Bank (EIB) is planning to lend Finland's Orion Euro 75m to help it stage pharmaceutical research and development work from this year to 2012.

Sign up for your free email newsletter

Part of a â"šÂ¬300m programme, the work would be carried out within Orion's existing r&d facilities, laboratories, pilot plants and clinical centres.

Companies

Featured Companies

Related Content

Orion and MSD announce global collaboration to develop and commercialise ODM-208
Orion and MSD announce global collaboration to develop and commercialise ODM-208
Nanoform and Orion collaborate on next-generation drug development
Nanoform and Orion collaborate on next-generation drug development
New Head and VP of Oncology Research at Orion Corporation
New Head and VP of Oncology Research at Orion Corporation
In the pursuit of new medicines for oncological diseases
In the pursuit of new medicines for oncological diseases
Endo and Orion agree collaboration deal
Endo and Orion agree collaboration deal
DelSiTech in research collaboration with Orion
DelSiTech in research collaboration with Orion